Search - tctmd.com

Displaying 1 - 20 of 29

Sort: Relevancy | Date

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for August 2024

Caitlin E. Cox

September 03, 2024

News Opinion Editor's Corner AHA 2023

What’s Going to Be Hot at AHA 2023

Shelley Wood

November 07, 2023

News Conference News ESC 2023

New ESC Guidelines for CVD in Patients With Diabetes Cover Wide Ground

Caitlin E. Cox

August 30, 2023

News Daily News

‘Speaking the Same Language’: New Guidance for Trials of Patients at High Bleeding Risk

Michael O'Riordan

September 16, 2020

News Conference News EuroPCR 2019

Off to EuroPCR 2019? Expect Mitral and Tricuspid Updates, Thin-Strut Stent Surprises, and ‘Strong’ Statements

Shelley Wood

May 16, 2019

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for October 2018

Shelley Wood

October 31, 2018

News Conference News TCT 2018

TCT 2018: Mitral Interventions, Stent Wars, Practical Skills, and More

Shelley Wood

September 17, 2018

Drug-eluting Balloon for the Treatment of de novo Coronary Artery Lesions in patients with high bleeding risk –a randomized controlled single-blind multicenter trial (DEBUT)

Presentation EuroPCR 2018

Drug-eluting Balloon for the Treatment of de novo Coronary Artery Lesions in patients with high bleeding risk (DEBUT trial)

Presenter: Tuomas Rissanen

May 26, 2018

News Conference News EuroPCR 2018

DCBs for CAD in Certain Patients With Large Vessel De Novo Disease? DEBUT Says Yes

Caitlin E. Cox

May 25, 2018

News Daily News

Time for Guidelines to Recommend ARBs Over ACE Inhibitors?

Shelley Wood

March 29, 2018

News Conference News TCT 2017

TCT 2017: High Hopes in Denver for Complex PCI, Shorter DAPT Durations, TAVR Costs, and More

Shelley Wood

October 20, 2017

News Features

The Bioresorbable Stent Story So Far: What Promise? What Price?

Michael O'Riordan

August 17, 2016

News Daily News

El Riego que Añaden los Cuadros de Shock a los IAM se Limita al los Primeros Meses Post- Alta Hospitalaria

Caitlin E. Cox

February 16, 2016

News Daily News

RITA 3 Publicado: La Estrategia Invasiva Rutinaria en SCASEST Pierde su Ventaja a los 10 Años

July 30, 2015

News Daily News

Subestudio BASKET-PROVE: Los SLF son Mejores que los SMD en Pacientes Ancianos con Arterias Grandes

Yael L. Maxwell

July 29, 2015

News Industry News

Celladon says may liquidate; suspends gene therapy development

June 29, 2015

News Daily News

El Posible Riesgo Cardiovascular de los IBP se Mantiene en 2 Nuevos Estudios

June 18, 2015

News Daily News

Un Meta Análisis Avala el Beneficio de la Revascularización Completa en el Manejo de STEMI

Todd Neale

June 11, 2015

News Daily News

Vorapaxar es Eficaz como Prevención Secundaria en Pacientes Diabéticos con Antecedentes de IM

L.A. McKeown

February 22, 2015

News Daily News

PROTECT: Menor Riesgo de Trombosis del Stent con el Endeavor a los 4 Años

L.A. McKeown

September 02, 2014

Advertisement

TCTMD’s Top 10 Most Popular Stories for August 2024

What’s Going to Be Hot at AHA 2023

New ESC Guidelines for CVD in Patients With Diabetes Cover Wide Ground

‘Speaking the Same Language’: New Guidance for Trials of Patients at High Bleeding Risk

Off to EuroPCR 2019? Expect Mitral and Tricuspid Updates, Thin-Strut Stent Surprises, and ‘Strong’ Statements

TCTMD’s Top 10 Most Popular Stories for October 2018

TCT 2018: Mitral Interventions, Stent Wars, Practical Skills, and More

Drug-eluting Balloon for the Treatment of de novo Coronary Artery Lesions in patients with high bleeding risk (DEBUT trial)

DCBs for CAD in Certain Patients With Large Vessel De Novo Disease? DEBUT Says Yes

Time for Guidelines to Recommend ARBs Over ACE Inhibitors?

TCT 2017: High Hopes in Denver for Complex PCI, Shorter DAPT Durations, TAVR Costs, and More

The Bioresorbable Stent Story So Far: What Promise? What Price?

El Riego que Añaden los Cuadros de Shock a los IAM se Limita al los Primeros Meses Post- Alta Hospitalaria

RITA 3 Publicado: La Estrategia Invasiva Rutinaria en SCASEST Pierde su Ventaja a los 10 Años

Subestudio BASKET-PROVE: Los SLF son Mejores que los SMD en Pacientes Ancianos con Arterias Grandes

Celladon says may liquidate; suspends gene therapy development

El Posible Riesgo Cardiovascular de los IBP se Mantiene en 2 Nuevos Estudios

Un Meta Análisis Avala el Beneficio de la Revascularización Completa en el Manejo de STEMI

Vorapaxar es Eficaz como Prevención Secundaria en Pacientes Diabéticos con Antecedentes de IM

PROTECT: Menor Riesgo de Trombosis del Stent con el Endeavor a los 4 Años

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content